Compare Revvity Inc (RVTY) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Consumer Staples Select Sector SPDR Fund trades at $83.38. The key difference: Revvity Inc pays a 0.23% dividend while Consumer Staples Select Sector SPDR Fund pays none, and Revvity Inc is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| RVTY | XLP | |
|---|---|---|
Market Cap | $13.82B | — |
Sector | Technology | — |
52-Week High | $130.94 | $90.00 |
52-Week Low | $82.26 | $75.61 |
Enterprise Value | $16.14B | — |
Dividend Yield | 0.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
XLP trades at $84.02, down 0.66% amid broader market volatility. The technical picture shows bearish momentum with key support at $83 and resistance at $85. Analyst sentiment remains strongly positive with 100% buy ratings, while recent news highlights XLP's defensive positioning during economic uncertainty as consumer spending shows signs of moderation.
XLP offers defensive exposure with strong institutional support, though technical weakness and economic headwinds create near-term pressure. The ETF's low expense ratio and dividend yield provide stability, but sector rotation risks and consumer spending trends warrant monitoring for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
